SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Hawkish Federal Reserve commentary, particularly Kevin Warshs emphasis on inflation and potential rate hikes, has driven a sharp selloff in rate-sensitive fintech stocks including SoFi. Traders are split between viewing higher rates as a major headwind and arguing that SoFis guidance already accounts for two hikes, making the decline an opportunity to accumulate.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention is centered on SELLAS CEO Angelos Stergious comments that rigorous, unblinded REGAL data will determine the outcome as the Phase 3 AML trial approaches its final event trigger, alongside favorable remarks from healthcare-industry professionals about GPS. Traders are split between optimism that the trial is nearing its decisive readout and skepticism fueled by a short report questioning the studys design; the final event count remains officially unconfirmed.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops amended convertible-note exchange, which fixes the stock portion and replaces further potential dilution with a cash settlement, is driving attention, with traders debating whether reduced dilution could enable buybacks and force bond-related short covering. Preliminary quarterly results showing sharply higher operating profit despite weaker sales are adding support, although bears question the quality of investment-driven gains and the companys outlook.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Unauthorized Grand Theft Auto VI gameplay leaks and anticipation of an official Netflix extended look are driving attention and volatility in Take-Two shares. Traders are divided between viewing the leaks as outdated footage and free publicity ahead of the scheduled launch, versus concerns about game quality, piracy, a possible delay, and hype already being priced in.

Corvex, Inc. is an AI cloud computing company, which specializes in GPU-accelerated infrastructure for AI workloads. Its products include GPU Clusters, Confidential Computing, Inference as a Service and GPU Node. The firm offers solutions include AI model builders, enterprises, federal and sovereign solutions. The company was founded by Seth Mitchell Demsey, Jay Crystal on October 21, 2024 and is headquartered in Arlington, VA.

Corvex Inc.

Movano Inc

Corvexs announced multi-year agreement to provide NVIDIA Blackwell GPU clusters to an AI infrastructure customer, alongside expanded data-center capacity, is driving attention. Traders are emphasizing the stocks perceived low float and short-squeeze potential, while skeptics point to dilution risk, speculative valuation, and execution uncertainty.

Better Home & Finance Holding Co. engages in the provision of comprehensive homeownership services. It offers mortgage loans, real estate agent services, and title and homeowner's insurance services. The company was founded in 2014 and is headquartered in New York, NY.

Better Home & Finance Holding Co. - Ordinary Shares - Class A

Better Home & Finance Holding Co.

The ongoing control battle between former CEO Vishal Garg and Betters board is driving attention, including a court denial of the boards temporary restraining order and Gargs continuing proxy campaign. Traders are split over which side would better support shareholders, while low float and elevated short interest are fueling speculation about a potential short squeeze.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

Attention is centered on the reported PanasonicJasmy/JANCTION collaboration advancing distributed GPU computing and Smart Render toward commercial AI, with traders viewing it as evidence of developing utility. Bulls are encouraged by the potential enterprise use cases, while skeptics question whether the collaboration creates direct JASMY demand and criticize the lack of clear communication.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Positive Phase 3 SHASTA-3 and SHASTA-4 results for plozasiran in severe hypertriglyceridemiashowing substantial triglyceride reductions and fewer acute-pancreatitis eventsare driving attention, alongside analyst upgrades and expectations for broader approval. Traders remain divided as the stocks pullback despite the data prompts debate over sell the news, competition from Ionis, valuation, and perceived options-related volatility.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

A quarterly earnings release drew attention after an earnings miss triggered a sharp selloff despite a revenue beat, raised full-year guidance, strong orders and backlog, and continued AI data-center power demand. Traders are split between viewing the decline as an overreaction and buying opportunity versus citing valuation, wind-segment weakness, tariffs, and execution risks.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

New post-hoc REDUCE-IT analyses presented at ESC 2026, including exploratory findings on adherence and lasting cardiovascular benefit, are driving attention. Supporters see the data as reinforcing Vascepas clinical and strategic value, while skeptics dismiss it as a rehash that does not change the label or offset generic pressure; traders are also debating Sarissas reported stake reduction and the ongoing strategic review.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jay Glenn

Longnstrongdong

StockTwits for iOS

Buffet87

@robcarroll all his messages carefully crafted by his legal team.

John

 all his messages carefully crafted by his legal team.

kvara

@robcarroll could be EAP? I.e. not strictly trial but clinical never the less?

StockTwits Web

 could be EAP? I.e. not strictly trial but clinical never the less?

Chris

@robcarroll I am in agreement with you 100%.  No way he does the interview without number 80 in hand.  IMO of course.

Bingo-Bango

 I am in agreement with you 100%.  No way he does the interview without number 80 in hand.  IMO of course.

InvestorCG

@robcarroll You really took this one hook, line and sinker.  Trying to give Stooge credit for his language is cute.  Everything is fluff, which it sort of has to be at this point.  He still crosses the line IMHO, but I would definitely not read anything into it. 
 
$SLS

 You really took this one hook, line and sinker.  Trying to give Stooge credit for his language is cute.  Everything is fluff, which it sort of has to be at this point.  He still crosses the line IMHO, but I would definitely not read anything into it. 
 


The Legendary Mayor

@robcarroll &quot;Novel&quot; Does NOT mean new, previously undisclosed.  Why are you lying?   
 
$SLS

 "Novel" Does NOT mean new, previously undisclosed.  Why are you lying?   
 


@robcarroll &quot;Clinical&quot;?  Seriously?  And it doesn&#39;t mean anything you post other than that&#39;s the stage they&#39;re in.  Why would you think this was a good idea to highlight?  Oozes desperation and attempting to stay relevant.  
 
Typical $SLS

 "Clinical"?  Seriously?  And it doesn't mean anything you post other than that's the stage they're in.  Why would you think this was a good idea to highlight?  Oozes desperation and attempting to stay relevant.  
 
Typical 

@robcarroll &quot;Developments&quot; is boiler plate.  There&#39;s NOTHING that should be gleaned by this.   
 
$SLS

 "Developments" is boiler plate.  There's NOTHING that should be gleaned by this.   
 


@robcarroll The phrase has one meaning...boiler plate language to say we&#39;ll talk to the Fox News audience next week and we&#39;re working on our talking points.   
 
$SLS

 The phrase has one meaning...boiler plate language to say we'll talk to the Fox News audience next week and we're working on our talking points.   
 


@robcarroll And the sheister always turns the comments off.  Probably too much heat for people calling him a scammer or too many people exposing $SLS&#39;s shortcomings.

 And the sheister always turns the comments off.  Probably too much heat for people calling him a scammer or too many people exposing 